KATI COUSINS: Open Payments
NPI 1841753043 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,448 in 32 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $319 · 2025 $1,448
Food & beverage: $1,448
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $381 |
| AstraZeneca Pharmaceuticals LP | 8 | $287 |
| Syndax Pharmaceuticals, Inc. | 3 | $193 |
| PharmaEssentia USA Corporation | 1 | $122 |
| Daiichi Sankyo Inc. | 4 | $101 |
| Merck Sharp & Dohme LLC | 3 | $86 |
| Rigel Pharmaceuticals, Inc. | 3 | $85 |
| BeOne Medicines USA, Inc. | 2 | $62 |
| Kite Pharma, Inc. | 2 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
Products named: OPDIVO, CALQUENCE, REVUFORJ, BREYANZI, BESREMI, Vanflyta, KEYTRUDA, TAVALISSE.
Industry payments across CA — which companies pay providers there.
